MA41551A
Bicyclic heterocycles as fgfr4 inhibitors
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Today
56 members in 25 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 201562118699 | United States of America | P | |
| 201562118699 | United States of America | P | |
| 201562192661 | United States of America | P | |
| 201562192661 | United States of America | P | |
| 201562118699P | – | – | – |
| 201562192661 | – | – | – |
| US201562118699P | – | – | – |
| US201562192661P | – | – | – |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| CA2976788A1 | Canada | A1 | |
| US2016244448A1 | United States of America | A1 | |
| WO2016134314A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201639839A | Taiwan Province of China | A | |
| AR103734A1 | Argentina | A1 | |
| AU2016219816A1 | Australia | A1 | |
| SG11201706495RA | Singapore | A | |
| CR20170388A | Costa Rica | A | |
| IL253869A0 | Israel | A0 | |
| IL253869D0 | Israel | D0 | |
| KR20170123634A | Republic of Korea | A | |
| ECSP17062716A | Ecuador | A | |
| CN107438608A | China | A | |
| MA41551AThis record | Morocco | A | |
| EP3259270A1 | European Patent Office (EPO) | A1 | |
| EA201791867A1 | Eurasian Patent Organization (EAPO) | A1 | |
| PE20180050A1 | Peru | A1 | |
| CO2017008824A2 | Colombia | A2 | |
| PH12017501483A1 | Philippines | A1 | |
| US9890156B2 | United States of America | B2 | |
| JP2018507214A | Japan | A | |
| CL2017002122A1 | Chile | A1 | |
| MX2017010672A | Mexico | A | |
| BR112017017727A2 | Brazil | A2 | |
| US2018244672A1 | United States of America | A1 | |
| US10214528B2 | United States of America | B2 | |
| US2019241560A1 | United States of America | A1 | |
| SG10201907582WA | Singapore | A | |
| UA121492C2 | Ukraine | C2 | |
| JP6716586B2 | Japan | B2 | |
| AU2016219816B2 | Australia | B2 | |
| US10738048B2 | United States of America | B2 | |
| JP2020147592A | Japan | A | |
| AU2020256431A1 | Australia | A1 | |
| US2020399267A1 | United States of America | A1 | |
| CN107438608B | China | B | |
| US11014923B2 | United States of America | B2 | |
| CN113024547A | China | A | |
| JP6903796B2 | Japan | B2 | |
| MY187265A | Malaysia | A | |
| TWI740818B | Taiwan Province of China | B | |
| IL253869A | Israel | A | |
| IL253869B | Israel | B | |
| TW202146415A | Taiwan Province of China | A | |
| US2022009921A1 | United States of America | A1 | |
| AU2020256431B2 | Australia | B2 | |
| MX2021006443A | Mexico | A | |
| BR112017017727A8 | Brazil | A8 | |
| US11667635B2 | United States of America | B2 | |
| CN113024547B | China | B | |
| TWI817189B | Taiwan Province of China | B | |
| CA2976788C | Canada | C | |
| BR112017017727B1 | Brazil | B1 | |
| KR102643180B1 | Republic of Korea | B1 | |
| NZ734594A | New Zealand | A | |
| NZ773115A | New Zealand | A |
Numbers
- Publication, EPODOC
- MA41551
- Application
- 41551
- Application, DOCDB
- 41551
- Application, EPODOC
- MA20160041551
Titles2
- English
- BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
- French
- HÉTÉROCYCLES BICYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE FGFR4
Classification
- CPC, 6
- C07D471/04
- C07D471/10
- A61P35/00
- A61P35/02
- A61K31/4375
- A61K31/519
- IPC, 3
- A61K31 519
- A61P35 00
- C07D471 04